Latest Ebitda Margin News

Centrepoint Alliance has completed its acquisition of a 51% controlling interest in SEQ Advice Group, initiating a phased ownership with deferred payments linked to future earnings.

Mayfield Childcare’s HY26 results reveal a 6% revenue decline and deepening statutory loss, offset by operational improvements and strategic restructuring.

BLS Pharmaceuticals (ASX: BLS) reported a standout FY26 with revenue surging 161% to $74.2 million and net profit more than tripling to $15.4 million, driven by expanded manufacturing and major international contracts including a $50 million German supply deal.

Simonds Group delivered a record net profit after tax of $10.5 million for FY26, driven by a 9.5% revenue rise to $729.1 million and strategic expansion including a Western Australia joint venture.

Verbrec Limited accelerated its growth trajectory in FY2026, driven by a strategic acquisition and divestment, delivering a 52% revenue increase and a near tripling of net profit.

BetMakers Technology Group Ltd (ASX: BET) reported solid FY26 financial results with revenue up 8.8% to $92.6 million and adjusted EBITDA surging 205% to $14.1 million. The company also announced a binding acquisition scheme with Tabcorp Holdings Limited.

Praemium Limited reported a 5.7% revenue increase to $110.5 million and a 21.1% jump in funds under administration to $77.9 billion for FY26, driven by strong high-net-worth segment growth and the integration of OneVue. The acquisition of Technotia Laboratories and a major technology restructure signal a sharpened focus on innovation and cost efficiency.

Carma Limited posted a 59% revenue jump to $113.8 million in FY26, doubling gross profit to $10.5 million, while gearing up to double reconditioning capacity and target positive EBITDA in 2027.

Beonic Limited has completed a three-year turnaround, reporting a profitable FY26 with EBITDA of A$4.0m and a 17.2% margin. The company’s unified spatial analytics platform and new AI product underpin FY27 growth guidance targeting ~A$20m ARR and a 19% EBITDA margin.

Resonance Health (ASX: RHT) reported a profitable turnaround in FY26, driven by growth across its imaging software, clinical trial services, and site network businesses.

Ashley Services Group delivered a standout FY26 with revenue up 16.7% to $602.2 million and net profit after tax surging 189.5% to $6.29 million, supported by margin gains across key sectors and a strategic acquisition.

PEXA Group delivered a solid FY26 with 7% revenue growth and a return to profitability, while facing a regulatory pricing review that could reshape its future investment capacity.